Skip to main content

and
  1. No Access

    Article

    The effect of human leukocyte antigen genotype on survival in advanced prostate cancer treated with primary androgen deprivation therapy: the KYUCOG-1401-A study

    Immune editing, in which human leukocyte antigens (HLA) have critical roles, has been suggested to shape the landscape of human cancer. This study prospectively investigated whether HLA gene zygosity is associ...

    Masaki Shiota, Tokiyoshi Tanegashima in Prostate Cancer and Prostatic Diseases (2024)

  2. No Access

    Article

    Prognostic significance of pathogenic variants in BRCA1, BRCA2, ATM and PALB2 genes in men undergoing hormonal therapy for advanced prostate cancer

    The prognostic significance of germline variants in homologous recombination repair genes in advanced prostate cancer (PCa), especially with regard to hormonal therapy, remains controversial.

    Hiroko Kimura, Kei Mizuno, Masaki Shiota, Shintaro Narita in British Journal of Cancer (2022)

  3. No Access

    Article

    Effect of HLA genotype on intravesical recurrence after bacillus Calmette–Guérin therapy for non-muscle-invasive bladder cancer

    The intravesical administration of bacillus Calmette–Guérin (BCG) is widely used to control the intravesical recurrence of non-muscle-invasive bladder cancer (NMIBC). This study aimed to reveal the effects of ...

    Mizuki Kobayashi, Nobuhiro Fujiyama in Cancer Immunology, Immunotherapy (2022)

  4. No Access

    Article

    Genome-wide association study of genetic variations associated with treatment failure after intravesical bacillus Calmette–Guérin therapy for non-muscle invasive bladder cancer

    Bacillus Calmette–Guérin (BCG) instillation is a key therapy to manage non-muscle invasive bladder cancer (NMIBC). However, intravesical BCG therapy fails in approximately half of the patients, leading to recu...

    Masaki Shiota, Naohiro Fujimoto, Yoshiaki Yamamoto in Cancer Immunology, Immunotherapy (2020)

  5. No Access

    Article

    The impact of genetic polymorphism on CYP19A1 in androgen-deprivation therapy among Japanese men

    Inadequate suppression of testosterone during androgen-deprivation therapy impairs its efficacy. This study investigated the significance of genetic polymorphism in CYP19A1, which encodes aromatase that catalyzes...

    Masaki Shiota, Naohiro Fujimoto in Cancer Chemotherapy and Pharmacology (2019)

  6. No Access

    Article

    CD163-positive cancer cells are potentially associated with high malignant potential in clear cell renal cell carcinoma

    CD163 is preferentially expressed by monocyte/macrophages; however, recent studies using immunohistochemistry (IHC) have reported that some cancer cells also express CD163. In the present IHC study, we investi...

    Chaoya Ma, Hasita Horlad, Koji Ohnishi, Takenobu Nakagawa in Medical Molecular Morphology (2018)

  7. No Access

    Article

    The significance of TIMD4 expression in clear cell renal cell carcinoma

    T-cell immunoglobulin and mucin domain (TIMD) family genes are related to innate immune responses. TIMD4 is a receptor for phosphatidylserine and is involved in the phagocytosis of apoptotic cells by macrophag...

    Hiromu Yano, Takanobu Motoshima, Chaoya Ma, Cheng Pan in Medical Molecular Morphology (2017)

  8. Article

    Open Access

    PD-L1 expression in papillary renal cell carcinoma

    The immune escape or tolerance of cancer cells is considered to be closely involved in cancer progression. Programmed death-1 (PD-1) is an inhibitory receptor expressed on activating T cells, and several types...

    Takanobu Motoshima, Yoshihiro Komohara, Chaoya Ma, Arni Kusuma Dewi in BMC Urology (2017)

  9. Article

    Open Access

    Definitive 3D-CRT for clinically localized prostate cancer: modifications of the clinical target volume following a prostate MRI and the clinical benefits

    To evaluate the modifications of the tumor stage and clinical target volume following a prostate magnetic resonance imaging (MRI) to evaluate the tumor (T) staging, and the clinical benefits for prostate cancer.

    Shinsaku Yamaguchi, Takayuki Ohguri, Masami Fujii, Katsuya Yahara in SpringerPlus (2015)

  10. No Access

    Article

    Efficacy of estramustine phosphate according to risk classification of castration-resistant prostate cancer

    Treatment options for patients who progressed to castration-resistant prostate cancer (CRPC) are very limited. The purpose of this study was to assess the efficacy of estramustine phosphate (EMP) in patients w...

    Akinori Minato, Naohiro Fujimoto, Tatsuhiko Kubo, Shuji Harada in Medical Oncology (2012)

  11. Article

    Open Access

    Duration of androgen deprivation therapy with maximum androgen blockade for localized prostate cancer

    Primary androgen deprivation therapy (ADT) is a treatment option not only for advanced but also for localized prostate cancer. However, the appropriate duration for primary ADT for localized prostate cancer ha...

    Naohiro Fujimoto, Tatsuhiko Kubo, Hideo Shinsaka, Masahiro Matsumoto in BMC Urology (2011)

  12. No Access

    Article

    The nationwide study of bacterial pathogens associated with urinary tract infections conducted by the Japanese Society of Chemotherapy

    This study was conducted by the Japanese Society of Chemotherapy and is the first nationwide study on bacterial pathogens isolated from patients with urinary tract infections at 28 hospitals throughout Japan b...

    Kiyohito Ishikawa, Tetsuro Matsumoto in Journal of Infection and Chemotherapy (2011)

  13. No Access

    Article

    Involvement of estrogen in the pathogenesis of cyclophosphamide-induced cystitis in rats

    We examined the effects of ovariectomy and castration on the histology of cyclophosphamide (CP)-induced cystitis in rats. The animals were injected with CP (100 mg/kg) or saline intraperitoneally twice with an...

    Michikazu Terado, Masayoshi Nomura MD, PhD, Kaori Mineta, Hisae Nishii in Endocrine (2005)

  14. No Access

    Article

    Differential induction of androgen receptor transactivation by different androgen receptor coativators in human prostate cancer DU 145 cells

    Recently identified androgen receptor (AR) coactivators were used in this study to determine whether the specificity of sex hormones and antiandrogens could be modulated at the coactivator level. We found that...

    Shuyuan Yeh, Hong-Yo Kang, Hiroshi Miyamoto, Kazuo Nishimura in Endocrine (1999)

  15. No Access

    Article

    Seiches in bays forming a coupled system

    The seiches occurring in two adjacent bays, Koaziro Bay and Moroiso Bay, situated in Miura Peninsula at the mouth of Tokyo Bay, are very regular, and the phenomenon of beat appears in their amplitudes of oscil...

    Masito Nakano, Naohiro Fujimoto in Journal of the Oceanographical Society of Japan (1987)